Login

Financial Snapshot

Revenue
TTM
$4.544M
Gross Margin
TTM
-65.05%
Net Income
TTM
-$27.58M
Current Assets
2022 Q3
Current Liabilities
2022 Q3
Current Ratio
2022 Q3
478.79%
Total Assets
2022 Q3
Total Liabilities
2022 Q3
Book Value
2022 Q3
$26.20M
Cash
2022 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$13.36M

Stock Price

Loading...
Market Cap: $5.828 Thousand

About PLx Pharma Winddown Corp.

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. The company is headquartered in Sparta, New Jersey and currently employs 16 full-time employees. The company went IPO on 2014-03-13. The firm is no longer into any business operations and it has filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code.

Industry: Pharmaceutical Preparations Peers: Ampio Pharmaceuticals, Inc. TREX WIND-DOWN, INC. cbdMD Inc Eloxx Pharmaceuticals Inc Evofem Biosciences Inc Johnson & Johnson Vyne Therapeutics Inc Unrivaled Brands, Inc. TITAN PHARMACEUTICALS INC Virpax Pharmaceuticals, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support